Representative Josh Gottheimer (D-New Jersey) recently sold shares of Azenta, Inc. (NASDAQ:AZTA). In a filing disclosed on April 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Azenta stock on March 19th. The trade occurred in the Representative’s “MORGAN STANLEY – SELECT UMA ACCOUNT # 1” account.
Representative Josh Gottheimer also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Visa (NYSE:V) on 3/24/2025.
- Sold $1,001 – $15,000 in shares of Spotify Technology (NYSE:SPOT) on 3/24/2025.
- Sold $1,001 – $15,000 in shares of Flywire (NASDAQ:FLYW) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Disco (OTCMKTS:DSCSY) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Diageo (NYSE:DEO) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Shopify (NYSE:SHOP) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk (NYSE:TLK) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 3/19/2025.
- Sold $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 3/19/2025.
Azenta Stock Up 0.7 %
Shares of NASDAQ AZTA opened at $26.71 on Monday. Azenta, Inc. has a fifty-two week low of $25.36 and a fifty-two week high of $63.58. The business has a 50 day moving average price of $39.42 and a two-hundred day moving average price of $44.72. The firm has a market cap of $1.22 billion, a PE ratio of -8.96 and a beta of 1.66.
Institutional Trading of Azenta
Several hedge funds have recently made changes to their positions in the stock. Lord Abbett & CO. LLC acquired a new stake in Azenta in the fourth quarter worth $47,350,000. Conestoga Capital Advisors LLC grew its position in shares of Azenta by 65.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock worth $78,894,000 after acquiring an additional 621,830 shares during the last quarter. Norges Bank acquired a new stake in shares of Azenta in the 4th quarter worth about $25,403,000. Schroder Investment Management Group lifted its position in Azenta by 46.7% in the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company’s stock valued at $70,183,000 after purchasing an additional 447,292 shares during the last quarter. Finally, Marshall Wace LLP acquired a new position in Azenta during the 4th quarter valued at about $20,469,000. Institutional investors own 99.08% of the company’s stock.
Analyst Upgrades and Downgrades
AZTA has been the topic of a number of research analyst reports. Needham & Company LLC increased their target price on Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Evercore ISI lifted their price objective on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. TD Cowen raised shares of Azenta to a “hold” rating in a report on Thursday, February 27th. Finally, Stephens reaffirmed an “overweight” rating and issued a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd.
Read Our Latest Stock Analysis on AZTA
About Representative Gottheimer
Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey’s 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027.
Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey’s 5th Congressional District. He declared candidacy for the 2026 election.
Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025.
Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- Dividend Capture Strategy: What You Need to Know
- Is McDonald’s Stock Serving a Value Meal to Investors?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Walgreens Comeback? Private Equity Circling for a Buyout
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.